Trial Outcomes & Findings for Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects (NCT NCT01145066)
NCT ID: NCT01145066
Last Updated: 2019-07-18
Results Overview
COMPLETED
PHASE2
80 participants
baseline
2019-07-18
Participant Flow
80 participants signed consent, only 71 were randomized to an arm/group
Participant milestones
| Measure |
Borage and Echium Oil Combination
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Overall Study
STARTED
|
26
|
20
|
25
|
|
Overall Study
COMPLETED
|
22
|
16
|
21
|
|
Overall Study
NOT COMPLETED
|
4
|
4
|
4
|
Reasons for withdrawal
| Measure |
Borage and Echium Oil Combination
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Overall Study
To resume NSAIDs
|
2
|
2
|
1
|
|
Overall Study
Non-related surgery
|
0
|
0
|
1
|
|
Overall Study
Withdrawal by Subject
|
0
|
0
|
2
|
|
Overall Study
To start new med
|
1
|
0
|
0
|
|
Overall Study
problems swallowing capsule
|
1
|
0
|
0
|
|
Overall Study
Abdominal discomfort
|
0
|
1
|
0
|
|
Overall Study
Low platelet count
|
0
|
1
|
0
|
Baseline Characteristics
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
Baseline characteristics by cohort
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
Total
n=59 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
57.4 years
STANDARD_DEVIATION 7.8 • n=93 Participants
|
56.2 years
STANDARD_DEVIATION 8.7 • n=4 Participants
|
59.9 years
STANDARD_DEVIATION 9.8 • n=27 Participants
|
57.96 years
STANDARD_DEVIATION 8.8 • n=483 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=93 Participants
|
10 Participants
n=4 Participants
|
15 Participants
n=27 Participants
|
35 Participants
n=483 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=93 Participants
|
6 Participants
n=4 Participants
|
6 Participants
n=27 Participants
|
24 Participants
n=483 Participants
|
PRIMARY outcome
Timeframe: baselineOutcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Fasting Insulin
|
15.4 μIU/mL
Standard Deviation 2.0
|
19.1 μIU/mL
Standard Deviation 4.5
|
20.2 μIU/mL
Standard Deviation 3.2
|
PRIMARY outcome
Timeframe: 4 weeks and 8 weeks combinedFasting insulin data at 4 and 8 weeks was averaged.
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Fasting Insulin
|
17.7 μIU/mL
Standard Deviation 2.6
|
24.6 μIU/mL
Standard Deviation 6.8
|
20.6 μIU/mL
Standard Deviation 3.3
|
PRIMARY outcome
Timeframe: baselineChanges in high sensitive C-reactive protein (hsCRP) were assessed.
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
hsCRP
|
3.03 mg/L
Standard Deviation .85
|
6.08 mg/L
Standard Deviation 3.19
|
2.36 mg/L
Standard Deviation .57
|
PRIMARY outcome
Timeframe: 4 weeks and 8 weeks combinedChanges in high sensitive C-reactive protein (hsCRP) were assessed and data at 4 and 8 weeks was averaged..
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
hsCRP
|
3.06 mg/L
Standard Deviation .86
|
3.59 mg/L
Standard Deviation 1.03
|
3.72 mg/L
Standard Deviation 1.00
|
PRIMARY outcome
Timeframe: baselineOutcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Leptin
|
33.3 ng/mL
Standard Deviation 6.2
|
45.1 ng/mL
Standard Deviation 11.0
|
53.5 ng/mL
Standard Deviation 6.8
|
PRIMARY outcome
Timeframe: 4 weeks and 8 weeks combinedData at 4 and 8 weeks was averaged.
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Leptin
|
33.9 ng/mL
Standard Deviation 7.4
|
40.6 ng/mL
Standard Deviation 7.2
|
44.2 ng/mL
Standard Deviation 5.3
|
SECONDARY outcome
Timeframe: baselineOutcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Serum Fatty Acids
C14:1
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
Cl4:0
|
.69 percentage of total fatty acids
Standard Deviation .08
|
.72 percentage of total fatty acids
Standard Deviation .07
|
.70 percentage of total fatty acids
Standard Deviation .07
|
|
Serum Fatty Acids
C15:0
|
.13 percentage of total fatty acids
Standard Deviation .02
|
.16 percentage of total fatty acids
Standard Deviation .02
|
.15 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C15:1
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C16:0
|
20.64 percentage of total fatty acids
Standard Deviation .41
|
21.65 percentage of total fatty acids
Standard Deviation .47
|
21.19 percentage of total fatty acids
Standard Deviation .40
|
|
Serum Fatty Acids
C16:1 n-7
|
1.58 percentage of total fatty acids
Standard Deviation .08
|
1.92 percentage of total fatty acids
Standard Deviation .24
|
1.68 percentage of total fatty acids
Standard Deviation .13
|
|
Serum Fatty Acids
C17:1
|
.10 percentage of total fatty acids
Standard Deviation .02
|
.13 percentage of total fatty acids
Standard Deviation .03
|
.08 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C18:0
|
7.23 percentage of total fatty acids
Standard Deviation .14
|
7.00 percentage of total fatty acids
Standard Deviation .25
|
7.47 percentage of total fatty acids
Standard Deviation .09
|
|
Serum Fatty Acids
C18:1
|
.12 percentage of total fatty acids
Standard Deviation .07
|
.17 percentage of total fatty acids
Standard Deviation .06
|
.21 percentage of total fatty acids
Standard Deviation .06
|
|
Serum Fatty Acids
C18:1 n-9
|
19.6 percentage of total fatty acids
Standard Deviation .44
|
21.92 percentage of total fatty acids
Standard Deviation .98
|
20.63 percentage of total fatty acids
Standard Deviation .96
|
|
Serum Fatty Acids
C18:1 n-11
|
1.5 percentage of total fatty acids
Standard Deviation .07
|
1.84 percentage of total fatty acids
Standard Deviation .06
|
1.60 percentage of total fatty acids
Standard Deviation .06
|
|
Serum Fatty Acids
C18:2 n-6 [LA]
|
32.67 percentage of total fatty acids
Standard Deviation .98
|
29.71 percentage of total fatty acids
Standard Deviation 1.28
|
31.99 percentage of total fatty acids
Standard Deviation 1.26
|
|
Serum Fatty Acids
C18:3 n-6 [GLA]
|
.59 percentage of total fatty acids
Standard Deviation .04
|
.55 percentage of total fatty acids
Standard Deviation .05
|
.53 percentage of total fatty acids
Standard Deviation .03
|
|
Serum Fatty Acids
C18:3 n-3 [ALA]
|
.80 percentage of total fatty acids
Standard Deviation .05
|
.77 percentage of total fatty acids
Standard Deviation .09
|
.73 percentage of total fatty acids
Standard Deviation .06
|
|
Serum Fatty Acids
C18:4 n-3 [SDA]
|
.01 percentage of total fatty acids
Standard Deviation .01
|
.01 percentage of total fatty acids
Standard Deviation .01
|
.03 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C20:0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
.01 percentage of total fatty acids
Standard Deviation .01
|
|
Serum Fatty Acids
C20:1 n-9
|
.04 percentage of total fatty acids
Standard Deviation .01
|
.10 percentage of total fatty acids
Standard Deviation .02
|
.08 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C20:2 n-6
|
.32 percentage of total fatty acids
Standard Deviation .01
|
.33 percentage of total fatty acids
Standard Deviation .02
|
.30 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C20:3 n-6 [DGLA]
|
1.51 percentage of total fatty acids
Standard Deviation .08
|
1.43 percentage of total fatty acids
Standard Deviation .09
|
1.68 percentage of total fatty acids
Standard Deviation .08
|
|
Serum Fatty Acids
C20:4 n-6 [AA]
|
9.12 percentage of total fatty acids
Standard Deviation .40
|
8.68 percentage of total fatty acids
Standard Deviation .40
|
8.17 percentage of total fatty acids
Standard Deviation .56
|
|
Serum Fatty Acids
C20:5 n-3 [EPA]
|
.573 percentage of total fatty acids
Standard Deviation .05
|
.56 percentage of total fatty acids
Standard Deviation .07
|
.48 percentage of total fatty acids
Standard Deviation .04
|
|
Serum Fatty Acids
C22:0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C22:1 n-9
|
.15 percentage of total fatty acids
Standard Deviation .06
|
0 percentage of total fatty acids
Standard Deviation 0
|
.05 percentage of total fatty acids
Standard Deviation .04
|
|
Serum Fatty Acids
C22:2 n-6
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C22:5 n-3 [DPA]
|
.55 percentage of total fatty acids
Standard Deviation .02
|
.59 percentage of total fatty acids
Standard Deviation .03
|
.54 percentage of total fatty acids
Standard Deviation .03
|
|
Serum Fatty Acids
C24:0
|
.02 percentage of total fatty acids
Standard Deviation .02
|
0 percentage of total fatty acids
Standard Deviation 0
|
.02 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C22:6 n-3 [DHA]
|
1.63 percentage of total fatty acids
Standard Deviation .10
|
1.73 percentage of total fatty acids
Standard Deviation .016
|
1.71 percentage of total fatty acids
Standard Deviation .12
|
|
Serum Fatty Acids
C24:1 n-9
|
.01 percentage of total fatty acids
Standard Deviation .01
|
.04 percentage of total fatty acids
Standard Deviation .02
|
.03 percentage of total fatty acids
Standard Deviation .02
|
SECONDARY outcome
Timeframe: 4 weeks and 8 weeks combinedData at 4 and 8 weeks was averaged.
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Serum Fatty Acids
C14:1
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C16:0
|
20.49 percentage of total fatty acids
Standard Deviation .37
|
20.76 percentage of total fatty acids
Standard Deviation .39
|
20.75 percentage of total fatty acids
Standard Deviation .37
|
|
Serum Fatty Acids
C16:1 n-7
|
1.39 percentage of total fatty acids
Standard Deviation .08
|
1.55 percentage of total fatty acids
Standard Deviation .14
|
1.57 percentage of total fatty acids
Standard Deviation .13
|
|
Serum Fatty Acids
C17:1
|
.05 percentage of total fatty acids
Standard Deviation .02
|
.06 percentage of total fatty acids
Standard Deviation .02
|
.04 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C24:0
|
.01 percentage of total fatty acids
Standard Deviation .01
|
.01 percentage of total fatty acids
Standard Deviation .01
|
.02 percentage of total fatty acids
Standard Deviation .01
|
|
Serum Fatty Acids
C22:6 n-3 [DHA]
|
1.63 percentage of total fatty acids
Standard Deviation .10
|
3.58 percentage of total fatty acids
Standard Deviation .11
|
1.60 percentage of total fatty acids
Standard Deviation .11
|
|
Serum Fatty Acids
Cl4:0
|
.66 percentage of total fatty acids
Standard Deviation .04
|
.62 percentage of total fatty acids
Standard Deviation .06
|
.66 percentage of total fatty acids
Standard Deviation .05
|
|
Serum Fatty Acids
C15:0
|
.14 percentage of total fatty acids
Standard Deviation .02
|
.14 percentage of total fatty acids
Standard Deviation .02
|
.14 percentage of total fatty acids
Standard Deviation .02
|
|
Serum Fatty Acids
C15:1
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C18:0
|
7.55 percentage of total fatty acids
Standard Deviation .16
|
7.39 percentage of total fatty acids
Standard Deviation .27
|
7.62 percentage of total fatty acids
Standard Deviation .12
|
|
Serum Fatty Acids
C18:1
|
.13 percentage of total fatty acids
Standard Deviation .05
|
.25 percentage of total fatty acids
Standard Deviation .06
|
.25 percentage of total fatty acids
Standard Deviation .05
|
|
Serum Fatty Acids
C18:1 n-9
|
19.60 percentage of total fatty acids
Standard Deviation .44
|
20.24 percentage of total fatty acids
Standard Deviation .52
|
20.30 percentage of total fatty acids
Standard Deviation .61
|
|
Serum Fatty Acids
C18:1 n-11
|
1.44 percentage of total fatty acids
Standard Deviation .05
|
1.56 percentage of total fatty acids
Standard Deviation .06
|
1.51 percentage of total fatty acids
Standard Deviation .06
|
|
Serum Fatty Acids
C18:2 n-6 [LA]
|
30.97 percentage of total fatty acids
Standard Deviation .80
|
29.94 percentage of total fatty acids
Standard Deviation 1.14
|
33.11 percentage of total fatty acids
Standard Deviation .93
|
|
Serum Fatty Acids
C18:3 n-6 [GLA]
|
1.2 percentage of total fatty acids
Standard Deviation .08
|
.45 percentage of total fatty acids
Standard Deviation .05
|
.52 percentage of total fatty acids
Standard Deviation .03
|
|
Serum Fatty Acids
C18:3 n-3 [ALA]
|
1.05 percentage of total fatty acids
Standard Deviation .05
|
.83 percentage of total fatty acids
Standard Deviation .06
|
.71 percentage of total fatty acids
Standard Deviation .05
|
|
Serum Fatty Acids
C18:4 n-3 [SDA]
|
.08 percentage of total fatty acids
Standard Deviation .01
|
.02 percentage of total fatty acids
Standard Deviation .01
|
.01 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C20:0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
.01 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C20:1 n-9
|
.04 percentage of total fatty acids
Standard Deviation .01
|
.03 percentage of total fatty acids
Standard Deviation .01
|
.05 percentage of total fatty acids
Standard Deviation .01
|
|
Serum Fatty Acids
C20:2 n-6
|
.24 percentage of total fatty acids
Standard Deviation .01
|
.23 percentage of total fatty acids
Standard Deviation .18
|
.31 percentage of total fatty acids
Standard Deviation .01
|
|
Serum Fatty Acids
C20:3 n-6 [DGLA]
|
1.97 percentage of total fatty acids
Standard Deviation .09
|
1.45 percentage of total fatty acids
Standard Deviation .07
|
1.61 percentage of total fatty acids
Standard Deviation .05
|
|
Serum Fatty Acids
C20:4 n-6 [AA]
|
9.16 percentage of total fatty acids
Standard Deviation .34
|
7.31 percentage of total fatty acids
Standard Deviation .36
|
8.11 percentage of total fatty acids
Standard Deviation .46
|
|
Serum Fatty Acids
C20:5 n-3 [EPA]
|
.89 percentage of total fatty acids
Standard Deviation .08
|
2.79 percentage of total fatty acids
Standard Deviation .18
|
.46 percentage of total fatty acids
Standard Deviation .05
|
|
Serum Fatty Acids
C22:0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C22:1 n-9
|
.15 percentage of total fatty acids
Standard Deviation .06
|
.19 percentage of total fatty acids
Standard Deviation .11
|
.11 percentage of total fatty acids
Standard Deviation .04
|
|
Serum Fatty Acids
C22:2 n-6
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
|
Serum Fatty Acids
C22:5 n-3 [DPA]
|
.55 percentage of total fatty acids
Standard Deviation .02
|
.89 percentage of total fatty acids
Standard Deviation .03
|
.51 percentage of total fatty acids
Standard Deviation .03
|
|
Serum Fatty Acids
C24:1 n-9
|
0 percentage of total fatty acids
Standard Deviation 0
|
0 percentage of total fatty acids
Standard Deviation 0
|
.01 percentage of total fatty acids
Standard Deviation .01
|
SECONDARY outcome
Timeframe: baselinePopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeks and 8 weeks combinedPopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: baselineOutcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Fasting Glucose
|
125.9 mg/dL
Standard Deviation 7.3
|
133.5 mg/dL
Standard Deviation 16.7
|
130.0 mg/dL
Standard Deviation 9.8
|
SECONDARY outcome
Timeframe: 4 weeks and 8 weeks combinedData at 4 and 8 weeks was averaged.
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Fasting Glucose
|
125.9 mg/dL
Standard Deviation 1.09
|
128.7 mg/dL
Standard Deviation 11.1
|
130.7 mg/dL
Standard Deviation 11.2
|
SECONDARY outcome
Timeframe: baselineOutcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Hemoglobin Levels
|
6.81 mg/dL
Standard Deviation .30
|
7.42 mg/dL
Standard Deviation .33
|
7.15 mg/dL
Standard Deviation .34
|
SECONDARY outcome
Timeframe: 4 weeks and 8 weeks combinedData at 4 and 8 weeks was averaged.
Outcome measures
| Measure |
Borage and Echium Oil Combination
n=22 Participants
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=16 Participants
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=21 Participants
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Hemoglobin Levels
|
6.90 mg/dL
Standard Deviation .27
|
7.20 mg/dL
Standard Deviation .32
|
7.07 mg/dL
Standard Deviation .35
|
SECONDARY outcome
Timeframe: 4 weeksPopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: baselinePopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeksPopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: baselinePopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeksPopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: baselinePopulation: No data collected
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 weeksPopulation: No data collected
Outcome measures
Outcome data not reported
Adverse Events
Borage and Echium Oil Combination
Fish Oil
Corn Oil
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Borage and Echium Oil Combination
n=26 participants at risk
borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA
borage/echium oil combination: borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA
|
Fish Oil
n=20 participants at risk
Croda 18:12 fish oil
fish oil: 1.6g/day EPA and 1.08g/day DHA
|
Corn Oil
n=25 participants at risk
corn oil: contains 4.5 g/day linoleic acid
|
|---|---|---|---|
|
Immune system disorders
Sick/virus
|
11.5%
3/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
15.0%
3/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
12.0%
3/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
|
Gastrointestinal disorders
GI Upset
|
0.00%
0/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
5.0%
1/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
0.00%
0/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
|
Nervous system disorders
Headache
|
3.8%
1/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
0.00%
0/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
0.00%
0/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
|
Metabolism and nutrition disorders
Weak
|
0.00%
0/26 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
5.0%
1/20 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
4.0%
1/25 • up to 8 weeks
Adverse Events were monitored/assessed without regard to the specific Adverse Event Term.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place